BCL2L11 and glioblastoma: In contrast, hypermethylation of CpG islands has been found at the promotor of the BCL2L11 gene encoding the pro-apoptotic protein BIM [162], and high levels of BIM were associated with resistance of GBM cells to EGFR inhibition-mediated treatment [163].